BGI
NRXP icon

B Group Inc’s NRX Pharmaceuticals NRXP Stock Holding History

B Group Inc’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Buy
+3,000,000
New +$6.06M 4.74% 7

Other funds holding NRXP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

B Group Inc's NRXP Position: Q1 2026 in Review

B Group Inc opened a new position in NRX Pharmaceuticals (NRXP) in Q1 2026: 3,000,000 shares worth $6.39M. The stake represents 4.74% of the portfolio and ranks #7 among its holdings.

33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • B Group Inc held 3,000,000 shares of NRX Pharmaceuticals worth $6.39M as of Q1 2026.
  • NRX Pharmaceuticals was a new B Group Inc position in Q1 2026.
  • NRX Pharmaceuticals made up 4.74% of B Group Inc's portfolio in Q1 2026, its #7 holding.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.